Clinical Trial Update: Feasibility of OmnEcoil System for Integrated Endorectal MRI and Transrectal MRI-Targeted Biopsy of the Prostate [NA]

View source ↗

Summary

The trial evaluating the OmnEcoil system for integrated endorectal MRI and MRI-targeted biopsy in prostate cancer has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: OHSU Knight Cancer Institute | Conditions: Prostate Carcinoma | NA | Status: SUSPENDED